157 related articles for article (PubMed ID: 9341900)
1. Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: a multivariate analysis of five antibodies.
Würl P; Taubert H; Meye A; Berger D; Lautenschläger C; Holzhausen HJ; Schmidt H; Kalthoff H; Rath FW; Dralle H
J Cancer Res Clin Oncol; 1997; 123(9):502-8. PubMed ID: 9341900
[TBL] [Abstract][Full Text] [Related]
2. [p53 overexpression as independent prognostic marker in soft tissue sarcomas is antibody dependent].
Würl P; Taubert H; Meye A; Berger D; Holzhausen HJ; Schmidt H; Hinze R; Rath FW; Schönfelder M
Verh Dtsch Ges Pathol; 1998; 82():358-61. PubMed ID: 10095460
[TBL] [Abstract][Full Text] [Related]
3. The p53 gene in soft tissue sarcomas: prognostic value of DNA sequencing versus immunohistochemistry.
Taubert H; Würl P; Bache M; Meye A; Berger D; Holzhausen HJ; Hinze R; Schmidt H; Rath FW
Anticancer Res; 1998; 18(1A):183-7. PubMed ID: 9568075
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of C-terminal Mdm2 detection is enhanced by p53 positivity in soft tissue sarcomas.
Würl P; Meye A; Berger D; Bache M; Lautenschläger C; Schmidt H; Kalthoff H; Rath FW; Taubert H
Diagn Mol Pathol; 1997 Oct; 6(5):249-54. PubMed ID: 9458382
[TBL] [Abstract][Full Text] [Related]
5. High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities.
Würl P; Meye A; Schmidt H; Lautenschläger C; Kalthoff H; Rath FW; Taubert H
Oncogene; 1998 Mar; 16(9):1183-5. PubMed ID: 9528860
[TBL] [Abstract][Full Text] [Related]
6. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of pRb and p53 co-overexpression in soft tissue sarcomas.
Würl P; Meye A; Lautenschläger C; Schmidt H; Bache M; Kalthoff H; Schönfelder M; Rath FW; Taubert H
Cancer Lett; 1999 May; 139(2):159-65. PubMed ID: 10395173
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of bcl-2 and p53 proteins and apoptosis in soft tissue sarcoma: their correlations with prognosis.
Nakanishi H; Ohsawa M; Naka N; Uchida A; Ochi T; Aozasa K
Oncology; 1997; 54(3):238-44. PubMed ID: 9143406
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas.
Drobnjak M; Latres E; Pollack D; Karpeh M; Dudas M; Woodruff JM; Brennan MF; Cordon-Cardo C
J Natl Cancer Inst; 1994 Apr; 86(7):549-54. PubMed ID: 8133539
[TBL] [Abstract][Full Text] [Related]
10. Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone.
Ueda Y; Dockhorn-Dworniczak B; Blasius S; Mellin W; Wuisman P; Böcker W; Roessner A
J Cancer Res Clin Oncol; 1993; 119(3):172-8. PubMed ID: 8418091
[TBL] [Abstract][Full Text] [Related]
11. p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
Silvestrini R; Benini E; Daidone MG; Veneroni S; Boracchi P; Cappelletti V; Di Fronzo G; Veronesi U
J Natl Cancer Inst; 1993 Jun; 85(12):965-70. PubMed ID: 8496982
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
Park HR; Park YK
J Korean Med Sci; 1995 Oct; 10(5):360-7. PubMed ID: 8750062
[TBL] [Abstract][Full Text] [Related]
13. Low detection rate of p53 antibodies in sera of soft tissue sarcoma patients.
Würl P; Fittkau M; Meye A; Bartel F; Schmidt H; Schönfelder M; Taubert H
Cancer Lett; 2001 Sep; 170(2):199-205. PubMed ID: 11463499
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
[TBL] [Abstract][Full Text] [Related]
15. p53 status in radiation-induced soft-tissue sarcomas.
Taubert H; Meye A; Bache M; Hinze R; Holzhausen HJ; Schmidt H; Rath FW; Dunst J; Würl P
Strahlenther Onkol; 1998 Aug; 174(8):427-30. PubMed ID: 9739384
[TBL] [Abstract][Full Text] [Related]
16. A multifactorial prognostic model for adult soft tissue sarcoma considering clinical, histopathological and molecular data.
Würl P; Lautenschläger C; Meye A; Schmidt H; Bache M; Rath FW; Schönfelder M; Taubert H
Anticancer Res; 2000; 20(3B):2065-72. PubMed ID: 10928153
[TBL] [Abstract][Full Text] [Related]
17. [Frequency, distribution and prognostic relevance of p53 mutations in soft tissue sarcomas].
Taubert H; Würl P; Meye A; Bache M; Kroll J; Lautenschläger C; Thamm B; Holzhausen HJ; Hinze R; Schmidt H; Berger D; Rath FW
Verh Dtsch Ges Pathol; 1998; 82():340-4. PubMed ID: 10095457
[TBL] [Abstract][Full Text] [Related]
18. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
19. Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240.
Wiman KG; Magnusson KP; Ramqvist T; Klein G
Oncogene; 1991 Sep; 6(9):1633-9. PubMed ID: 1923530
[TBL] [Abstract][Full Text] [Related]
20. p53 expression in non small cell lung cancer: clinical and biological correlations.
Fontanini G; Bigini D; Vignati S; Macchiarini P; Pepe S; Angeletti CA; Pingitore R; Squartini F
Anticancer Res; 1993; 13(3):737-42. PubMed ID: 8100413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
